Blocking uPAR mesenchymal function with an antibody (R3) against uPAR domain-1, thereby masking the uPA binding site, resulted into a decrease of invasion which was similar in all the examined cancer cell lines (figure 1D). The gene discussed is PLAUR; the disease is cancer.